Cerner Co. (NASDAQ:CERN) VP Jeffrey A. Townsend sold 230,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $61.94, for a total transaction of $14,246,200.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Cerner Co. (CERN) opened at $64.22 on Friday. The stock has a market cap of $21,290.00, a P/E ratio of 24.99, a P/E/G ratio of 1.92 and a beta of 0.90. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.01 and a quick ratio of 2.99. Cerner Co. has a one year low of $54.01 and a one year high of $73.86.
Cerner (NASDAQ:CERN) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.03). The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.33 billion. Cerner had a net margin of 16.86% and a return on equity of 16.82%. The business’s revenue was up 4.5% compared to the same quarter last year. During the same period last year, the business earned $0.61 earnings per share. equities analysts anticipate that Cerner Co. will post 2.42 EPS for the current fiscal year.
A number of large investors have recently made changes to their positions in CERN. Dimensional Fund Advisors LP boosted its position in Cerner by 7.4% in the second quarter. Dimensional Fund Advisors LP now owns 697,200 shares of the company’s stock valued at $46,342,000 after buying an additional 47,812 shares in the last quarter. State of Wisconsin Investment Board boosted its position in Cerner by 16.8% in the third quarter. State of Wisconsin Investment Board now owns 425,712 shares of the company’s stock valued at $30,362,000 after buying an additional 61,326 shares in the last quarter. Harrington Investments INC acquired a new stake in Cerner in the third quarter valued at approximately $1,675,000. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its position in Cerner by 5.7% in the third quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 45,080 shares of the company’s stock valued at $3,215,000 after buying an additional 2,426 shares in the last quarter. Finally, Shell Asset Management Co. boosted its position in Cerner by 201.0% in the third quarter. Shell Asset Management Co. now owns 57,749 shares of the company’s stock valued at $3,440,000 after buying an additional 38,565 shares in the last quarter. 81.58% of the stock is currently owned by institutional investors and hedge funds.
Several brokerages have recently commented on CERN. Royal Bank of Canada reaffirmed a “buy” rating on shares of Cerner in a report on Wednesday, October 25th. Jefferies Group reaffirmed a “buy” rating on shares of Cerner in a report on Sunday, October 29th. Cantor Fitzgerald lowered their target price on shares of Cerner from $83.00 to $80.00 and set an “overweight” rating on the stock in a report on Wednesday, February 7th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $70.00 target price on shares of Cerner in a report on Thursday, November 30th. Finally, Citigroup began coverage on shares of Cerner in a report on Thursday, January 4th. They set a “neutral” rating on the stock. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and eight have assigned a buy rating to the company. Cerner currently has an average rating of “Hold” and a consensus price target of $67.05.
Cerner Company Profile
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.